A photo of Rajaram Nagarajan.

Clinical Director, Division of Oncology

Co-Director, Cardio-Oncology Program

Co-Director, Cancer Survivor Center

Associate Professor, UC Department of Pediatrics

513-636-0670

513-636-3549

Board Certified

My Biography & Research

Biography

Dr. Nagarajan is a pediatric oncologist who specializes in the care of patients with cancer and patients who have completed their therapy.

Clinical Interests

Bone tumors; late effects of pediatric cancer therapy

Research Interests

Outcomes following cancer therapy and bone sarcomas

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Cancer and Blood Diseases, Kidney Tumor, Sarcoma, Retinoblastoma, Cardio-Oncology, Oncology, Cancer and Blood Diseases

My Locations

My Education

BA: Pre-Medical Sciences, Lehigh University, Bethlehem, PA, 1991.

MD: Medical College of Pennsylvania, Philadelphia, PA, 1995.

Internship and Residency: Pediatrics, Medical College of Virginia, Richmond, VA, 1998.

Fellowship Training: Hematology / Oncology / BMT, University of Minnesota, Minneapolis, MN, 2002.

MS: Clinical Research, University of Minnesota, Minneapolis, MN, 2002.

Certifications: Pediatrics, Pediatric Hematology / Oncology.

My Publications

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. Calaminus, G; Jenney, M; Hjorth, L; Baust, K; Bernstein, M; Bielack, S; Vos, PD; Hogendoorn, PC W; Jovic, G; Krailo, M; et al. JMIR Research Protocols. 2019; 8:e14406-e14406.

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group. Nagarajan, R; Gerbing, R; Alonzo, T; Johnston, DL; Aplenc, R; Kolb, EA; Meshinchi, S; Barakat, LP; Sung, L. Cancer Medicine. 2019; 8:4454-4464.

Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients. Ryan, TD; Nagarajan, R; Godown, J. Current Treatment Options in Oncology. 2019; 20.

Study of Delayed Antibiotic in Pediatric Febrile Immunocompromised Patients and Adverse Events. Fananapazir, N; Dandoy, C; Byczkowski, T; Lane, A; Nagarajan, R; Hariharan, S. Hospital Pediatrics. 2019; 9:379-386.

Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group. Holmqvist, AS; Chen, Y; Teh, JB; Sun, C; Birch, JM; van den Bos, C; Diller, LR; Dilley, K; Ginsberg, J; Martin, LT; et al. Cancer. 2019; 125:1373-1383.

Sentinel lymph node biopsy in head and neck rhabdomyosarcoma. Turpin, B; Pressey, JG; Nagarajan, R; Weiss, BD; Trout, AT; Gelfand, MJ; Pater, L; Vatner, RE; Breneman, JC; Dasgupta, R. Pediatric Blood and Cancer. 2019; 66:e27532-e27532.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Smeland, S; Bielack, SS; Whelan, J; Bernstein, M; Hogendoorn, P; Krailo, MD; Gorlick, R; Janeway, KA; Ingleby, FC; Anninga, J; et al. European Journal of Cancer. 2019; 109:36-50.

Cardiopulmonary Aerobic Fitness Assessment During Maximal and Submaximal Exercise Testing in Pediatric Oncology Patients After Chemotherapy. Powell, AW; Nagarajan, R; Mays, WA; Chin, C; Knilans, TK; Knecht, SK; Amos, MA; Gerdes, YM; Ryan, TD. American Journal of Clinical Oncology: cancer clinical trials. 2018; 41:1058-1061.

Pazopanib therapy for desmoid tumors in adolescent and young adult patients. Agresta, L; Kim, H; Turpin, BK; Nagarajan, R; Plemmons, A; Szabo, S; Dasgupta, R; Sorger, JI; Pressey, JG. Pediatric Blood and Cancer. 2018; 65:e26968-e26968.

Rehabilitation of the pediatric cancer patient. Pruitt, DW; Bolikal, P. In: Stubblefield M; O'Dell M, Ed. Cancer Rehabilitation: Principles and Practice, Second Edition. New York: Demos Medical Publishing; 2018.